v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities:    
Net loss $ (48,915,000) $ (24,466,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Foreign exchange loss 45,000
Depreciation of fixed assets 895,000 771,000
Amortization of intangible assets 133,000 132,000
Amortization of right-of-use assets 942,000 853,000
Amortization of debt issuance costs 595,000
Share-based compensation 9,488,000 4,603,000
Change in fair value of financial instrument 5,690,000 2,956,000
Loss on extinguishment of debt 1,186,000 838,000
Loss on disposal of property and equipment 111,000
Non-cash interest settled through share conversions 1,495,000
Impairment of fixed assets 838,000
Credit loss expense 933,000 100,000
Inventory net realizable value adjustment 745,000
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (328,000) (395,000)
Contract assets 498,000 (1,070,000)
Inventory (4,249,000) 130,000
Other assets (2,323,000) 1,347,000
Accounts payable 3,799,000 (2,798,000)
Accrued expenses 2,961,000 (515,000)
Earn out payable (150,000) (200,000)
Right-of-use liabilities (1,036,000) (773,000)
Contract liabilities 6,029,000 (302,000)
Net cash used in operating activities (20,775,000) (18,634,000)
Cash flows from investing activities:    
Purchases of property and equipment (4,008,000) (505,000)
Net cash used in investing activities (4,008,000) (505,000)
Cash flows from financing activities:    
Cash paid for tax withholding related to shares withheld (807,000) (649,000)
Payment of debt issuance costs (524,000)
Proceeds from convertible notes 26,500,000 3,173,000
Payment on convertible notes (5,974,000)
Proceeds from issuance of common stock - At The Market offering, net of issuance costs 7,592,000 17,729,000
Proceeds from issuance of common stock - Capital Raise, net of issuance costs 2,450,000
Net cash provided by financing activities 26,787,000 22,703,000
Net increase in cash, cash equivalents and restricted cash 2,004,000 3,564,000
Cash, cash equivalents and restricted cash, beginning of year 6,869,000 3,305,000
Cash, cash equivalents and restricted cash, end of year 8,873,000 6,869,000
Supplemental disclosure of noncash investing and financing activities:    
Common stock issued related to bonus and earnout payments 630,000
Common stock issued related to conversion of convertible debt 18,432,000 2,956,000
Operating right of use asset obtained in exchange for operating lease liability $ 1,276,000